Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Congenital Cmv topic
No spam. Unsubscribe anytime.
Parents, clinicians urge universal newborn screening, education for congenital CMV
Summary
Multiple families and clinicians told the Joint Committee on Public Health that congenital cytomegalovirus (cCMV) screening and prenatal education should be universal in Massachusetts, citing cases where missed testing prevented timely antiviral treatment during the 21-day window that can preserve hearing and development.
Parents, clinicians and audiologists told the Joint Committee on Public Health that Massachusetts should adopt universal newborn screening and standardized prenatal education for congenital cytomegalovirus (cCMV) to prevent missed treatment opportunities that can cause lifelong hearing and developmental disabilities.
"By the time we learned the truth, it was too late," Danielle LaVaughn told the committee about her son Ryan, who lost hearing before clinicians could treat him. "A window missed not because we weren't paying attention, but because the system wasn't built to." Her husband Keith described the communications and logistical challenges families face and urged coverage to remove financial barriers.
Witnesses representing families and health systems described the cCMV problem in three parts: lack of routine prenatal counseling that would teach expectant parents simple infection-prevention steps, inconsistent testing of newborns in the critical 21-day window, and uneven hospital protocols for follow-up and treatment. "Most infants born with congenital CMV don't show any signs at birth. Without universal screening, these children are missed," said Dr. Cheryl Glovsky, a pediatric audiologist at Mass Eye and Ear.
Several families recounted charts or test results that sat in the medical record without timely follow-up. Vanessa Colleran, who lost her son Logan to cCMV, said she only learned late that the virus is common and that simple precautions in pregnancy reduce risk: "Why is it that everyone knows about Zika... but no one knows about CMV, a very similar virus that is all around us?" she asked. Clinicians and students described published studies and state pilots in Connecticut and Utah as models for Massachusetts, and urged the committee to recommend Senate Bill 15-73 and companion House measures.
What happened next: the committee heard testimony in support of S 15-73 and related bills but did not take a recorded vote at the hearing. Advocates asked for a favorable report and offered to provide educational materials and screening pilot data to DPH.
Ending: Parents and clinicians asked the Joint Committee to move the measure forward so newborns and families can benefit from early testing and interventions.
